Status:

UNKNOWN

Low-Dose Intravenous Ketamine for Adolescents With Depression and Suicidal Ideation in the Emergency Department

Lead Sponsor:

Rady Children's Hospital, San Diego

Collaborating Sponsors:

University of California, San Diego

Conditions:

Depression

Suicidal Ideation

Eligibility:

All Genders

12-18 years

Phase:

EARLY_PHASE1

Brief Summary

The goal of this study is to test whether a single low-dose of IV ketamine given in the emergency department to adolescents with treatment-resistant depression and suicidal ideation can reduce depress...

Detailed Description

This study will be a double-blinded, randomized, placebo-controlled trial. Study investigators and trained research assistants (RAs) will identify eligible participants from the electronic ED tracking...

Eligibility Criteria

Inclusion

  • Determined, based upon medical and social work evaluation, to require inpatient psychiatric admission without further need for medical diagnostic evaluation and treatment.
  • Treatment-resistant depression (defined as failure of response to trials of at least 2 antidepressant courses, each of at least 4 weeks' duration)
  • Parent/guardian available for consent (in person or by phone)

Exclusion

  • Any of the following co-existing diagnoses: primary psychotic disorder (schizophrenia, schizoaffective) autism spectrum disorder, developmental delay/intellectual disability, substance abuse disorder within the last 6 months
  • Aggressive behavior, homicidal ideation
  • Altered mental status
  • Pregnancy or breastfeeding,
  • Currently receiving (or receipt within last 24 hours) medication acting on NMDA receptor system (lamotrigine, dextromethorphan, methadone, clarithromycin, amantadine)
  • Incomplete medical evaluation or stabilization
  • Contraindications to or anaphylaxis or prior adverse reaction to Ketamine
  • No caregiver available
  • In custody of a law enforcement agency

Key Trial Info

Start Date :

March 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2024

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT05217706

Start Date

March 1 2022

End Date

January 1 2024

Last Update

February 16 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rady Children's Hospital San Diego

San Diego, California, United States, 92123